August 2015 FDA Recall Drug by Apotex Inc.
D-1814-2015 - Failed Stability Specifications

This Class II drug recall was voluntarily initiated by Apotex Inc. on August 17, 2015 for the product Drug. The FDA reported the reason for recall as failed stability specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1814-2015

Reason for Recall
Failed Stability Specifications: product may not meet specification limit for assay test.
Initiated
08-17-2015
Reported
09-23-2015
Quantity
117,644 Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide and Puerto Rico
Cevimeline Hydrochloride Capsules, 30 mg a) 100 count bottle, and b) 500 count bottle, Rx Only, Manufactured by: Apotex Research Pvt., Ltd., Bangalore, India, Manufactured for: Apotex Corp, Westin, FL, a) NDC 60505-3145-1, b) NDC 60505-3145-5

Batch or Lot Expiration Information

Lot# s: a) KP9749, KT3501, Exp 09/2015, KP4524, Exp 11/2015, KV8264, Exp 01/2016, KX8713, KX8714, KX8715, Exp 04/2016; b) KP4525, Exp 11/2015, KP9750, Exp 12/2015, KX8716, Exp 04/2016